红日药业: insider trades · France · AMF SZSE:300026 FR FR · AMF Mcap 10.6Bn€
Discover the full insider trade history of 红日药业, a listed equity based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €10.6bn. The latest transaction was filed on 23 May 2023 — Sale. Among the most active insiders: 姚小青. All data is openly available.
Financial data FY ended December 2024 · cache
Income statement
Revenue 5.78 Bn€
Gross profit 3.05 Bn€ 53% margin
Net income 21.5 M€ 0.4% margin
Balance sheet & cash
Market cap 10.57 Bn€
Total debt 852.1 M€
Free Cash Flow 659.1 M€
Last declaration on 23 May 2023
Declarations 17 total
Executives ● Sale7 SZSE
5,000,000 shares
SZSE:173000006614180260 · 23 May 2023
Executives ● Sale7 SZSE
2,300,000 shares
SZSE:173000006282518050 · 15 Feb 2023
Executives ● Sale7 SZSE
999,900 shares
SZSE:173000006264759740 · 8 Feb 2023
Executives ● Sale7 SZSE
3,005,700 shares
SZSE:173000006108880060 · 5 Dec 2022
Executives ● Sale7 SZSE
12,100 shares
SZSE:173000006080902200 · 25 Nov 2022
Executives ● Sale7 SZSE
10,000 shares
SZSE:173000005992969200 · 27 Oct 2022
Executives ● Sale7 SZSE
36,500 shares
SZSE:173000005720876260 · 26 Jul 2022
Executives ● Sale7 SZSE
700,000 shares
SZSE:173000005704023330 · 21 Jul 2022
Executives ● Sale7 SZSE
635,500 shares
SZSE:173000005700821820 · 20 Jul 2022
Executives ● Sale7 SZSE
620,000 shares
SZSE:173000005689829470 · 15 Jul 2022
Executives ● Sale7 SZSE
120,000 shares
SZSE:173000005652389200 · 4 Jul 2022
Executives ● Sale7 SZSE
3,710,000 shares
SZSE:173000005607954800 · 20 Jun 2022
Executives ● Sale7 SZSE
4,200,000 shares
SZSE:173000005605692400 · 17 Jun 2022
Executives ● Sale7 SZSE
1,700,000 shares
SZSE:173000005585460640 · 10 Jun 2022
Executives ● Sale22 SZSE
225,900 shares
SZSE:173000005210097920 · 7 Jan 2022
Executives ● Sale7 SZSE
2,353,000 shares
SZSE:173000004904940320 · 23 Sept 2021
Executives ● Sale7 SZSE
12,500,000 shares
SZSE:173000004577012930 · 19 Jul 2021